Joint with: Hematopoiesis
Myeloid Cells: Functional Heterogeneity with Therapeutic Promise

Feb 23–26, 2026 | Keystone Resort, Keystone, CO, United States
Scientific Organizers: Charlotte L. Scott, Shalin H. Naik, and Thomas Fabre

  In Person
  On Demand
 Add to Calendar
×

-

Feb 23–26, 2026 | Keystone Resort, Keystone, CO, United States

Scientific Organizers: Charlotte L. Scott, Shalin H. Naik, and Thomas Fabre

Supported by the  Directors' Fund

***Meeting program subject to change.

Available Formats:   = In Person     = On Demand
Monday, February 23, 2026
Registration
4:00–8:00 PM
Welcome Mixer
6:00–8:00 PM
Tuesday, February 24, 2026
Breakfast
7:00–8:00 AM
Welcome and Keynote Address
8:00–9:00 AM
Shannon J Turley, Genentech, Inc.
Manipulating Stromal-Myeloid Cell Crosstalk for Therapeutic Purposes
Myeloid Cell Development, Recruitment and Fate
9:00–11:15 AM
Shalin H. Naik, Walter & Eliza Hall Institute
Barcoding Human and Mouse Haematopoiesis
Elizabeth Wayne, University of Washington
Engineering Monocyte Cell Fate in Disease
Heping Xu, Westlake University
Airway Neutrophil Recruitment by Alarmin-Loaded Extracellular Lipid Droplets
Short Talk(s) Chosen from Abstracts
Coffee Break
9:30–9:50 AM
Poster Setup
11:15–1:00 PM
On Own for Lunch
11:15–2:30 PM
Poster Viewing
1:00–10:00 PM
Symposia Spotlight 1: Late-breaking research presentations selected from abstract submissions
2:30–4:30 PM
Short Talks Chosen from Abstracts
Coffee Available
4:30–5:00 PM
Myeloid Cells in Tumors
5:00–7:00 PM
Ariel Munitz, Tel Aviv University
Eosinophils in the Tumor Microenvironment
Stefani Spranger, Massachusetts Institute of Technology
The Role of Dendritic Cells in Shaping Anti-Tumor Immunity
Jennifer Guerriero, Brigham and Women's Hospital
Myeloid Cells as Immunotherapy for Breast Cancer
Short Talk(s) Chosen from Abstracts
Social Hour with Dinner
7:00–8:00 PM
Posters
7:30–10:00 PM
Wednesday, February 25, 2026
Breakfast
7:00–8:00 AM
Myeloid Cell Functions in Disease Contexts
8:00–11:00 AM
Charlotte L. Scott, University of Ghent & VIB
Role of Lipid-Associated Macrophages in Tissue Injury
Lai Guan Ng, Shanghai Immune Therapy Institute
Harnessing Neutrophil Heterogeneity for Biomarker Development and Targeted Treatment
Hawa Racine Thiam, Stanford University
Engineering NETosis in Disease
Florent Ginhoux, Gustave Roussy
DC Heterogeneity in Disease
Short Talk(s) Chosen from Abstracts
Coffee Break
9:00–9:20 AM
Poster Setup
11:00–1:00 PM
On Own for Lunch
11:00–5:00 PM
Poster Viewing
1:00–10:00 PM
Career Roundtable (Joint)
1:45–2:45 PM
Panel Discussion: Making Sense of the Mess: How to Bring Together the Different Subsets Identified using scRNA-Seq in Different Studies
3:00–4:30 PM
Coffee Available
4:30–5:00 PM
Functional Heterogeneity of Myeloid Cells Across Tissues
5:00–7:00 PM
Kurt Zimmerman, University of Oklahoma Health Sciences Center
Functional Heterogeneity of Kidney Macrophages
Isabelle C Arnold, University of Zurich
Eosinophils in the Gastrointestinal Tract
David Sancho, Centro Nacional de Investigaciones Cardiovasculares, CNIC
Metabolic Control of Myeloid Cell Function
Short Talk(s) Chosen from Abstracts
Social Hour with Dinner
7:00–8:00 PM
Posters
7:30–10:00 PM
Thursday, February 26, 2026
Breakfast
7:00–8:00 AM
Myeloid Cells in Infection
8:00–11:00 AM
Calum C. Bain, University of Edinburgh
Role of Macrophages in Pulmonary Infections
Lidia Bosurgi, University Medical Center Hamburg-Eppendorf
Harnessing Macrophage Efferocytosis to Promote Tissue Repair and Remodeling
Bryan D. Bryson, Massachusetts Institute of Technology
Reprogramming Myeloid Cells to Improve Bacterial control
Short Talk(s) Chosen from Abstracts
Coffee Break
9:00–9:20 AM
On Own for Lunch
11:00–2:30 PM
Symposia Spotlight 2: Going from scRNA-seq to Meaningful Biology
2:30–4:30 PM
Short Talks Chosen from Abstracts
Coffee Available
4:30–5:00 PM
Targeting Myeloid Cells in Disease
5:00–7:00 PM
Thomas Fabre, Pfizer
Utilizing Macrophages to Treat Fibrosis
Filipe Pereira, Lund University and Asgard Therapeutics
Conversion of Cancer Cells into Dendritic Cells to Reinstate Cancer Immunity
Adam Freund, Arda Therapeutics
Evaluating the Consequences of Antibody-Drug Conjugate-Mediated Depletion of Myeloid Cells in Liver Fibrosis
Kristen Radford, University of Queensland
Human DCs in Cancer Models
Short Talk(s) Chosen from Abstracts
Meeting Wrap-Up: Outcomes and Future Directions
7:00–7:15 PM
Social Hour with Dinner
7:15–8:15 PM
Entertainment
8:00–11:00 PM
Cash Bar
8:00–11:00 PM
Friday, February 27, 2026
Departure
12:00–11:59 PM

Subscribe for Updates